杰德生物科技 JBIO
$15.07 +$0.97 (+6.88%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $15.36 +1.92%
开盘$14.16
昨收$14.10
当日区间$13.65 – $15.11
成交量596.5K
市值$958.41M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$58.92M-112.1% YoY
净利润-$55.77M-73.5% YoY
摊薄每股收益-$0.76+11.6% YoY
自由现金流-$43.66M-115.1% YoY
经营现金流-$43.66M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
盈利能力与资产负债表
净资产收益率-47.8%
资产收益率-44.0%
投入资本回报率-49.9%
流动比率14.93
负债/资产比率6.8%
现金及投资$461.21M
总负债$628,000.00
净现金（净负债）$460.58M
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| -其他流动负债变动 | -$30,000.00 | -$29,000.00 | $40,000.00 | -$28,000.00 | $68,000.00 |
| -其他流动资产变动 | $0.00 | $0.00 | -$38,000.00 | – | – |
| -应付账款及应计费用变动 | $1.69M | $3.93M | $3.77M | -$274,000.00 | -$632,000.00 |
| -预付资产变动 | -$2.83M | $5.44M | -$11.97M | -$10.20M | -$413,000.00 |
| 营运资金变动 | -$1.17M | $9.34M | -$8.20M | -$10.54M | -$1.07M |
| 其他非现金项目 | $25,000.00 | $26,000.00 | $21.67M | $26,000.00 | -$17,000.00 |
| 折旧、折耗与摊销 | $9,000.00 | $9,000.00 | $26,000.00 | $9,000.00 | $12,000.00 |
| 持续经营净利润 | -$55.77M | -$40.37M | -$127.41M | -$31.93M | -$25.18M |
| 持续经营经营活动现金流净额 | -$43.66M | -$24.08M | -$94.69M | -$33.65M | -$22.12M |
| 经营活动现金流 | -$43.66M | -$24.08M | -$94.69M | -$33.65M | -$22.12M |
| 投资活动现金流净额 | -$97.63M | -$8.47M | -$247.01M | -$98.16M | -$148.71M |
| 期初现金余额 | $55.09M | $88.44M | $69.39M | $50.11M | $220.94M |
| 期末现金余额 | $107.25M | $55.09M | $88.44M | $88.44M | $50.11M |
| 其他筹资费用净额 | $0.00 | -$840,000.00 | $171.27M | $171.12M | $0.00 |
| 股票期权行使所得 | $2.12M | $45,000.00 | $384,000.00 | – | – |
| 现金净变动 | $52.24M | -$33.35M | $19.07M | $38.35M | -$170.83M |
| 汇率变动影响 | -$70,000.00 | -$7,000.00 | -$21,000.00 | -$17,000.00 | -$4,000.00 |
| 持续经营筹资活动现金流净额 | $193.52M | -$795,000.00 | $360.77M | $170.16M | $0.00 |
| 筹资活动现金流 | $193.52M | -$795,000.00 | $360.77M | $170.16M | $0.00 |
| 投资购置及出售净额 | -$97.63M | -$8.47M | -$246.78M | -$98.19M | -$148.59M |
| 自由现金流 | -$43.66M | -$24.08M | -$94.89M | -$33.65M | -$22.18M |
| 持续经营投资活动现金流净额 | -$97.63M | -$8.47M | -$247.01M | -$98.16M | -$148.71M |
| 固定资产购置及出售净额 | – | – | -$196,000.00 | -$3,000.00 | -$57,000.00 |
| 其他投资变动净额 | – | – | -$31,000.00 | $28,000.00 | – |
| 债务发行及偿还净额 | – | – | $0.00 | $0.00 | – |
| 普通股发行净额 | – | – | $189.11M | -$1.34M | $0.00 |
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 ANNUAL | 2025 Q3 |
|---|---|---|---|---|---|
| 非经营性利息收入 | $3.23M | $3.10M | $3.09M | $7.78M | $2.25M |
| 摊薄每股收益 | -$0.76 | -$0.57 | -$0.65 | -$3.19 | -$0.48 |
| 基本每股收益 | -$0.76 | -$0.57 | -$0.65 | -$3.19 | -$0.48 |
| 归属普通股股东净利润 | -$55.77M | -$40.37M | -$31.93M | -$127.41M | -$25.18M |
| 归属母公司净利润 | -$55.77M | -$40.37M | -$31.93M | -$127.41M | -$25.18M |
| 净利润 | -$55.77M | -$40.37M | -$31.93M | -$127.41M | -$25.18M |
| 税费 | $15,000.00 | $16,000.00 | – | $58,000.00 | – |
| 税前利润 | -$55.75M | -$40.35M | -$31.87M | -$127.35M | -$25.18M |
| 其他非经营性收入（支出） | -$62,000.00 | -$9,000.00 | $20,000.00 | -$21.59M | -$28,000.00 |
| 其他收入（支出） | -$62,000.00 | -$9,000.00 | $20,000.00 | -$21.59M | -$28,000.00 |
| 持续经营利润 | -$55.77M | -$40.37M | -$31.93M | -$127.41M | -$25.18M |
| 营业费用 | $58.92M | $43.45M | $34.98M | $113.54M | $27.40M |
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 销售及管理费用 | $8.85M | $7.39M | $6.44M | $20.42M | $5.39M |
| -管理费用 | $8.85M | $7.39M | $6.44M | $20.42M | $5.39M |
| 研发费用 | $50.07M | $36.05M | $28.54M | $93.12M | $22.01M |
| 营业利润 | -$58.92M | -$43.45M | -$34.98M | -$113.54M | -$27.40M |
| 非经营性利息净收入（支出） | $3.23M | $3.10M | $3.09M | $7.78M | $2.25M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 ANNUAL | 2025 Q3 |
|---|---|---|---|---|---|
| 其他流动资产 | $10.05M | $7.22M | $12.66M | $12.66M | $2.46M |
| 非流动资产合计 | $862,000.00 | $916,000.00 | $965,000.00 | $965,000.00 | $1.09M |
| 固定资产净值 | $793,000.00 | $847,000.00 | $896,000.00 | $896,000.00 | $916,000.00 |
| -固定资产原值 | $793,000.00 | $847,000.00 | $896,000.00 | $896,000.00 | $916,000.00 |
| 其他非流动资产 | $69,000.00 | $69,000.00 | $69,000.00 | $69,000.00 | $174,000.00 |
| 负债合计 | $32.20M | $22.97M | $17.26M | $17.26M | $23.10M |
| 流动负债合计 | $31.57M | $22.29M | $16.54M | $16.54M | $22.36M |
| 应付款 | $6.58M | $3.98M | $2.15M | $2.15M | $1.35M |
| -现金及现金等价物 | $107.25M | $55.09M | $88.44M | $88.44M | $50.11M |
| 现金及现金等价物与短期投资 | $461.21M | $311.30M | $336.16M | $336.16M | $198.91M |
| 流动资产合计 | $471.25M | $318.52M | $348.82M | $348.82M | $201.36M |
| 总资产 | $472.11M | $319.43M | $349.78M | $349.78M | $202.45M |
| -应付账款 | $6.58M | $3.98M | $2.15M | $2.15M | $1.35M |
| 一年内应计费用 | $11.30M | $12.90M | $11.07M | $11.07M | $12.96M |
| 不影响留存收益的损益 | -$660,000.00 | -$342,000.00 | $129,000.00 | $129,000.00 | $29,000.00 |
| 资本公积 | $711.09M | $511.55M | $506.77M | $506.77M | $321.77M |
| 其他流动负债 | $9.77M | $2.67M | – | – | $4.95M |
| 非流动负债合计 | $628,000.00 | $679,000.00 | $724,000.00 | $724,000.00 | $747,000.00 |
| 长期债务及融资租赁负债 | $628,000.00 | $679,000.00 | $724,000.00 | $724,000.00 | $747,000.00 |
| -长期融资租赁负债 | $628,000.00 | $679,000.00 | $724,000.00 | $724,000.00 | $747,000.00 |
| 股东权益合计 | $439.92M | $296.46M | $332.52M | $332.52M | $179.35M |
| 股东权益 | $439.92M | $296.46M | $332.52M | $332.52M | $179.35M |
| 股本 | $8,000.00 | $7,000.00 | $7,000.00 | $7,000.00 | $5,000.00 |
| -普通股 | $6,000.00 | $5,000.00 | $5,000.00 | $5,000.00 | $3,000.00 |
| -优先股 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 |
| -短期投资 | $353.96M | $256.21M | $247.72M | $247.72M | $148.80M |
| 留存收益 | -$270.52M | -$214.76M | -$174.39M | -$174.39M | -$142.46M |
| 可转换优先证券 | – | – | $0.00 | $0.00 | $0.00 |
暂无评论——快来第一个聊聊 JBIO。